HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leahy Loads Congressional Food Safety Plate With Criminal Charges Bill

This article was originally published in The Tan Sheet

Executive Summary

Senate Judiciary Committee Chairman Patrick Leahy's bill specifying criminal charges in cases of adulterated food products could derail chances for broader food safety enforcement reform to pass

You may also be interested in...



In Brief

Journal article says BTC class "feasible"

UNPA "Advertiser Beware" Seminar In Brief

Oregon DOJ advises on avoiding substantiation trouble: To avoid receiving a dietary supplement substantiation claim request from Oregon's Department of Justice, companies should build a firewall between their marketing and claims substantiation departments. At the United Natural Products Alliance's Sept. 24 seminar on advertising regulations, Oregon DOJ attorney David Hart said in a recent case a company official in charge of claims substantiation also worked with the marketing department. "You see the conflict of interest here? That's just untenable," said Hart, who is in charge of financial fraud/consumer protection. "A person who does the substantiation review should be uncontaminated." Best practices include reaching outside a firm for substantiation, such as to independent academic medical centers, and having substantiation ready before it is requested. "Don't send me a box full of Internet studies. If I ask you for substantiation and you just throw a bunch of studies in a box, I know you don't know what you're talking about," Hart added. Having information ready indicates a company is acting in good faith, even if the government disagrees with the research findings, he said. Additionally, substantiation materials should be updated regularly to remain current with research

FDA Plays Misdemeanor Card In Adulterated Supplement Prosecution

FDA's Office of Criminal Investigations assists in prosecuting the maker of "all-natural" sexual enhancement drugs, an action in line with its strategy to seek more misdemeanor charges against violative food and drug firms

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel